Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market pois
Posted by rohan on November 6th, 2017
According to the report Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market, published by Market Data Forecast, the Middle East and Africa market is projected to reach USD 294.28 million by 2021, at a CAGR of 6.69% from 2016 to 2021.
Ischemic stroke is the result of a dysfunction in the blood supply to the brain because of the emboli, atherosclerosis or thrombus occurring in cerebral arteries. As per a World Health Organization (WHO) estimate, approximately 17 million people die annually because of cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases, globally. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Stroke is one of the leading cause of long term disability, occurring at a higher rate in the old age population. Moreover, stroke leads to 1 out of every 20 deaths, costing around billion to U.S. annually. Higher rates of mortality due to strokes jars up an imminent need for innovative drugs and diagnostic devices.
Get a comprehensive overview of the Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-acute-ischemic-stroke-diagnosis-market-270/
Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: Drivers & Restraints
The advancements in the surgical devices technology, in addition with the rising occurrence of acute ischemia stroke cases among the patients are some of the dominant driving factor for the surgery in acute stroke treatment. Some of the other factors driving the market include, aging population mainly in the developed countries of Middle East and Africa. The development of the effective medication in the treatment of ischemic stroke is accepted to hinder the acceptance of expensive surgery in the ischemic stroke diagnosis market. The development of desmoteplase, a novel next-generation thrombolytic, is one of the major advancement of in the treatment technology of acute ischemic stroke. It provides extended therapeutic time compared to most of the other treatment procedure. Moreover, with the increasing impact of telemedicine and e-prescription and e-medical adherence the acute ischemic stroke diagnosis and treatment market is expected to flourish at a healthy rate during the forecast period.
The major hindrance in the development of acute ischemic stroke diagnosis and treatment market is in the clinical trial, which include long testing of drug after stroke onset, in addition to insufficient selection of patients for the trials.
Get accurate market forecast and analysis on the Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-acute-ischemic-stroke-diagnosis-market-270/request-sample
Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: Segmentation
By Diagnostic type
By Surgery type
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-acute-ischemic-stroke-diagnosis-market-270/customize-report
Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: Overview
Based on surgery type, this market was dominated by carotid endaterectomy in 2013, owing to easier availability, shorter length of treatment time, and a greater success rate. This segment could, however, experience a fall in market shares due to the presence of major side effects. Though CT has commanded the Middle East and Africa acute ischemic stroke diagnosis and treatment market thus far, it is projected to be gradually replaced by the MRI method, due to lower costs and higher efficiency.
Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: Region-wise Outlook
The Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment market is geographically categorized into Middle East and Africa. Middle East is the largest market in this region due to high disposable income. Africa is the estimated to be the fastest growing region due to high population base and increasing incidence of various cardiovascular diseases such as Ischemic stroke.
Key Questions Answered
Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market: Key Players
Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.
Reasons to buy Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market Report:
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author